59820-92-7 Usage
Uses
Used in Pharmaceutical Industry:
6-Bromo-7-nitro-2,3-dihydro-1,4-benzodioxine is utilized as a pharmaceutical intermediate for the synthesis of various drug compounds. Its unique structure and functional groups make it a key component in the development of new medications.
Used in Medicinal Chemistry Research:
BNBD is employed as a scaffold in medicinal chemistry for the design and synthesis of new drug candidates. Its structural features allow for modifications that can enhance the pharmacological properties of potential therapeutic agents.
Used in Organic Synthesis:
6-Bromo-7-nitro-2,3-dihydro-1,4-benzodioxine serves as a versatile building block in organic synthesis, enabling the creation of a wide range of chemical compounds with diverse applications.
Used in Preclinical Studies:
In the field of preclinical research, BNBD is used to study its anticonvulsant and antihypertensive properties, providing insights into its potential therapeutic applications in treating neurological disorders and cardiovascular conditions.
Used in Drug Development:
6-Bromo-7-nitro-2,3-dihydro-1,4-benzodioxine is applied in drug development processes to create new pharmaceutical entities with improved efficacy and safety profiles, targeting a variety of medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 59820-92-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,8,2 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 59820-92:
(7*5)+(6*9)+(5*8)+(4*2)+(3*0)+(2*9)+(1*2)=157
157 % 10 = 7
So 59820-92-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H6BrNO4/c9-5-3-7-8(14-2-1-13-7)4-6(5)10(11)12/h3-4H,1-2H2
59820-92-7Relevant academic research and scientific papers
HETEROCYCLIC LSF INHIBITORS AND THEIR USES
-
, (2021/07/31)
The present invention is directed to heterocyclic SV40 Factor (LSF) inhibitors and their uses. In some implementations, the present invention discloses small-molecule compounds of Formula (I). In some implementations, the compounds of Formula (I) are used
